Human CNS immune senescence and neurodegeneration

Current Opinion in Immunology

Volumn 29, Issue 1, 2014, Pages 93-96

  Streit, Wolfgang J ^a   Xue, Qing Shan ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GERIATRIC PATIENT; HIGH RISK POPULATION; HUMAN; IMMUNE SENESCENCE; IMMUNOLOGICAL PARAMETERS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; AGING; ANIMAL; CELL AGING; IMMUNOLOGY; INFLAMMATION;

AGING; ANIMALS; CELL AGING; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES;

EID: 84902008578     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.05.005     Document Type: Review

References (31)

1. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013, 10:43.
2. Frick L.R., Williams K., Pittenger C. Microglial dysregulation in psychiatric disease. Clin Dev Immunol 2013, 2013:608654.
3. Streit W.J., Mrak R.E., Griffin W.S. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004, 1:14.
4. Streit W.J., Xue Q.S. Microglial senescence. CNS Neurol Disord Drug Targets 2013, 12:763-767.
5. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987, 79:195-200.
6. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988, 9:339-349.
7. McGeer P.L., Itagaki S., McGeer E.G. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 1988, 76:550-557.
8. Streit W.J. Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front Aging Neurosci 2010, 2:22.
9. Giulian D. Reactive glia as rivals in regulating neuronal survival. Glia 1993, 7:102-110.
10. Giulian D., Haverkamp L.J., Li J., Karshin W.L., Yu J., Tom D., Li X., Kirkpatrick J.B. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 1995, 27:119-137.
11. McGeer P.L., McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001, 22:799-809.
12. Smith A.M., Dragunow M. The human side of microglia. Trends Neurosci 2014.
13. Graeber M.B., Li W., Rodriguez M.L. Role of microglia in CNS inflammation. FEBS Lett 2011, 585:3798-3805.
14. Streit W.J., Xue Q.S., Braak H., Del Tredici K. Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain. Glia 2014, 62:96-105.
15. Arvanitakis Z., Grodstein F., Bienias J.L., Schneider J.A., Wilson R.S., Kelly J.F., Evans D.A., Bennett D.A. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology 2008, 70:2219-2225.
16. Halliday G.M., Shepherd C.E., McCann H., Reid W.G., Grayson D.A., Broe G.A., Kril J.J. Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Arch Neurol 2000, 57:831-836.
17. Martin B.K., Szekely C., Brandt J., Piantadosi S., Breitner J.C., Craft S., Evans D., Green R., Mullan M. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol 2008, 65:896-905.
18. Streit W.J., Braak H., Xue Q.S., Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 2009, 118:475-485.
19. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
20. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004, 77:1-8.
21. Neumann H., Kotter M.R., Franklin R.J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
22. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2005, 7:221-232.
23. Njie E.G., Boelen E., Stassen F.R., Steinbusch H.W., Borchelt D.R., Streit W.J. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging 2012, 33. 195 e191-112.
24. Krabbe G., Halle A., Matyash V., Rinnenthal J.L., Eom G.D., Bernhardt U., Miller K.R., Prokop S., Kettenmann H., Heppner F.L. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 2013, 8:e60921.
25. Hickman S.E., Allison E.K. El Khoury J: Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008, 28:8354-8360.
26. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 2013, 368:107-116.
27. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., et al. TREM2 variants in Alzheimer's disease. N Engl J Med 2013, 368:117-127.
28. Neumann H., Daly M.J. Variant TREM2 as risk factor for Alzheimer's disease. N Engl J Med 2013, 368:182-184.
29. Golde T.E., Streit W.J., Chakrabarty P. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease. Alzheimers Res Ther 2013, 5:24.
30. Gu B.J., Baird P.N., Vessey K.A., Skarratt K.K., Fletcher E.L., Fuller S.J., Richardson A.J., Guymer R.H., Wiley J.S. A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration. FASEB J 2013, 27:1479-1487.
31. Fellner L., Jellinger K.A., Wenning G.K., Stefanova N. Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 2011, 121:675-693.